These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114 [TBL] [Abstract][Full Text] [Related]
7. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Englund JA; Champlin RE; Wyde PR; Kantarjian H; Atmar RL; Tarrand J; Yousuf H; Regnery H; Klimov AI; Cox NJ; Whimbey E Clin Infect Dis; 1998 Jun; 26(6):1418-24. PubMed ID: 9636873 [TBL] [Abstract][Full Text] [Related]
8. Measures for control of influenza. Couch RB Pharmacoeconomics; 1999; 16 Suppl 1():41-5. PubMed ID: 10623375 [TBL] [Abstract][Full Text] [Related]
9. Amantadine and rimantadine for the prevention of influenza A. Betts RF Semin Respir Infect; 1989 Dec; 4(4):304-10. PubMed ID: 2697053 [TBL] [Abstract][Full Text] [Related]
10. Antivirals for influenza: what is their role in the older patient? Dumyati G; Falsey AR Drugs Aging; 2002; 19(10):777-86. PubMed ID: 12390054 [TBL] [Abstract][Full Text] [Related]
11. Use of antivirals in influenza in the elderly: prophylaxis and therapy. Nicholson KG Gerontology; 1996; 42(5):280-9. PubMed ID: 8940651 [TBL] [Abstract][Full Text] [Related]
13. A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection. Marra F; Marra CA; Stiver HG Can Respir J; 2003 Oct; 10(7):381-8. PubMed ID: 14571290 [TBL] [Abstract][Full Text] [Related]
14. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005. Barr IG; Hurt AC; Iannello P; Tomasov C; Deed N; Komadina N Antiviral Res; 2007 Feb; 73(2):112-7. PubMed ID: 16963130 [TBL] [Abstract][Full Text] [Related]
15. Antiviral agents for influenza: a comparison of cost-effectiveness data. Lynd LD; Goeree R; O'Brien BJ Pharmacoeconomics; 2005; 23(11):1083-106. PubMed ID: 16277546 [TBL] [Abstract][Full Text] [Related]
17. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses. Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313 [TBL] [Abstract][Full Text] [Related]
18. Amantadine and rimantadine for influenza A in children and the elderly. Alves Galvão MG; Rocha Crispino Santos MA; Alves da Cunha AJ Cochrane Database Syst Rev; 2008 Jan; (1):CD002745. PubMed ID: 18254006 [TBL] [Abstract][Full Text] [Related]
19. Rimantadine: a clinical perspective. Wintermeyer SM; Nahata MC Ann Pharmacother; 1995 Mar; 29(3):299-310. PubMed ID: 7606077 [TBL] [Abstract][Full Text] [Related]
20. Influenza vaccination and antiviral therapy: is there a role for concurrent administration in the institutionalised elderly? Drinka PJ Drugs Aging; 2003; 20(3):165-74. PubMed ID: 12578397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]